stella
beta
Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery — Stella
Recruiting
Back to Glaucoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Panama
Panama Eye Center, Panama City
View full record on ClinicalTrials.gov